Searched for
MITSUBISHI PHARMA
SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....- Stocks in news: SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis BankIndian markets saw volatile trading on Thursday, closing nearly unchanged despite positive signals. Several companies including SBI, Titan,...
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....
- Global Markets | Japanese shares pare gains on doubts over Trump's Iran remarksJapanese shares pared gains on Tuesday as investors remained unconvinced that U.S. President Donald Trump's comments about holding off on t...
- Japan's Nikkei slips a second day as AI, chemical shares give up gainsJapan's Nikkei share average fell for a second day, impacted by profit-taking in AI stocks and escalating trade tensions with China. The Ni...
- Japan's Nikkei snaps 7-day winning streak as US tariff worries weighNikkei witnessed a slight dip, ending a seven-session winning streak. Pharma stocks fell after Donald Trump's tariff announcement. Automake...
- 'Blackstone, Bain to bid for Mitsubishi Pharma unit in up to $3.5 billion deal'Mitsubishi Chemical has hired Goldman Sachs to run the sale process and binding bids are due on Dec. 24, the sources said. Local private eq...
- Nikkei ends 2% higher on bargain-buying, led by tech shares"The Japanese market fell too much in the previous sessions because of concerns about the impact of the Omicron variant, which is affecting...
- Mitsubishi UFJ Financial sells 2.10% shares in CiplaPrior to the sale, MUFG had 5.56 per cent shares in Cipla.
- Nikkei closes flat even as chip makers make a buzzChip equipment makers jumped, tracking a rise in US tech shares overnight.
- Nikkei turns up, marks 4th day of gains on US-China trade hopesThe Nikkei share average ended 0.2 per cent higher to 21,464.23.
- Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...
- Japanese companies make cautious return to Indian pharma marketOther drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.
- Sun Pharma strikes distribution alliance with Mitsubishi Tanabe in JapanSun’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor.
- Japanese company loses patent bid for diabetes drugThe Kolkata Patent Office, on an opposition filed by domestic drug firm Lupin, refused the patent application on grounds that it was "obvio...
- Japan asks Prime Minister Narendra Modi to clear policy hurdles for companiesToyota, on the other hand, has been facing labour unrest that hit production at its plant in Bidadi, about 30 km from Bangalore.
- Top stocks: RIL, TCS,Rel Cap, Natco Pharma, Persistent SystemsThe Indian markets are likely to open on a flat-to-positive note on the back of supportive cues from global peers.
- A question of chemistryPharma-Chemical onvergence model is distinctly on hold, the world over.
- Auto biggies set the pace for FDI flowsIndia attracted foreign direct investment (FDI) to the tune of $1.74bn during April-July ’06, registering a 47% growth over the $1.18bn inf...
- 47% growth in FDI inflows: Kamal NathIndia attracted FDI to the tune of $1.74 billion duirng April-July 2006, registering a 47% growth over the inflow during the corresponding ...
Load More
